As of 2025-03-24, the Relative Valuation of Beam Therapeutics Inc (BEAM) is (171.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.30 USD, the upside of Beam Therapeutics Inc based on Relative Valuation is -836.1%.
The range of the Relative Valuation is (141.44) - (218.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 48.6x | 41.5x |
| Forward P/E multiples | 26.9x - 48.9x | 34.7x |
| Fair Price | (141.44) - (218.87) | (171.51) |
| Upside | -707.0% - -1039.4% | -836.1% |
| Date | P/E |
| 2025-03-19 | -5.25 |
| 2025-03-18 | -5.02 |
| 2025-03-17 | -5.45 |
| 2025-03-14 | -5.38 |
| 2025-03-13 | -5.57 |
| 2025-03-12 | -6.09 |
| 2025-03-11 | -5.87 |
| 2025-03-10 | -5.71 |
| 2025-03-07 | -6.33 |
| 2025-03-06 | -6.05 |
| 2025-03-05 | -5.80 |
| 2025-03-04 | -5.87 |
| 2025-03-03 | -5.58 |
| 2025-02-28 | -5.85 |
| 2025-02-27 | -6.02 |
| 2025-02-26 | -6.20 |
| 2025-02-25 | -6.63 |
| 2025-02-24 | -6.84 |
| 2025-02-21 | -6.76 |
| 2025-02-20 | -7.36 |
| 2025-02-19 | -7.57 |
| 2025-02-18 | -7.44 |
| 2025-02-14 | -7.20 |
| 2025-02-13 | -6.36 |
| 2025-02-12 | -6.35 |
| 2025-02-11 | -5.96 |
| 2025-02-10 | -5.90 |
| 2025-02-07 | -6.09 |
| 2025-02-06 | -6.14 |
| 2025-02-05 | -6.18 |
| 2025-02-04 | -5.72 |
| 2025-02-03 | -5.68 |
| 2025-01-31 | -5.76 |
| 2025-01-30 | -6.06 |
| 2025-01-29 | -5.76 |
| 2025-01-28 | -5.61 |
| 2025-01-27 | -5.76 |
| 2025-01-24 | -5.77 |
| 2025-01-23 | -5.84 |
| 2025-01-22 | -5.86 |
| 2025-01-21 | -5.45 |
| 2025-01-17 | -5.21 |
| 2025-01-16 | -5.20 |
| 2025-01-15 | -5.20 |
| 2025-01-14 | -5.18 |
| 2025-01-13 | -5.67 |
| 2025-01-10 | -5.86 |
| 2025-01-08 | -5.95 |
| 2025-01-07 | -6.02 |
| 2025-01-06 | -5.86 |